Medtronic 2016 Annual Report Download - page 131
Download and view the complete annual report
Please find page 131 of the 2016 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121 -
122 -
123 -
124 -
125 -
126 -
127 -
128 -
129 -
130 -
131 -
132 -
133 -
134 -
135 -
136 -
137 -
138 -
139 -
140 -
141 -
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
 |
 |
Table of Contents
Medtronic plc
Notes to Consolidated Financial Statements (Continued)
128
intercompany dividend. The Company also made revisions to the Condensed Consolidating Statement of Cash Flows of the
guarantees of the CIFSA Senior Notes as previously presented in Note 19 in the Company’s Annual Report on Form 10-K for the
year ended April 24, 2015. An approximately $8.0 billion revision to cash from investing and financing activities was made in
both the Subsidiary Issuer (CIFSA) and Subsidiary Non-Guarantors columns, as well as a $1.3 billion revision to cash from
investing and operating activities in the Subsidiary Guarantors column related to an incorrect presentation of intercompany loan
activity. A $937 million revision to cash from operating and investing activities in the Subsidiary Issuer (CIFSA) column and
operating and financing activities in the Subsidiary Non-Guarantors column was related to an incorrect presentation of an
intercompany capital contribution. The Company made certain revisions to its consolidating financial statements of the guarantees
of the Medtronic Senior Notes as previously presented in Note 19 in the Company’s Annual Report on Form 10-K for the years
ended April 24, 2015 and April 25, 2014. There is no impact to the consolidated financial statements of Medtronic plc as previously
filed in the 2015 Annual Report on Form 10-K or Quarterly Reports on Form 10-Q.